BAYER HEALTHCARE LLC FDA Approval NDA 020526

NDA 020526

BAYER HEALTHCARE LLC

FDA Drug Application

Application #020526

Application Sponsors

NDA 020526BAYER HEALTHCARE LLC

Marketing Status

Discontinued002

Application Products

002CREAM, TABLET;TOPICAL, VAGINAL1%,200MG1GYNE-LOTRIMIN 3 COMBINATION PACKCLOTRIMAZOLE

FDA Submissions

TYPE 8; Type 8 - Partial Rx to OTC SwitchORIG1AP1996-07-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1998-03-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1998-12-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2000-02-22STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2001-05-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2001-03-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2002-01-16STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0

CDER Filings

BAYER HEALTHCARE LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20526
            [companyName] => BAYER HEALTHCARE LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"GYNE-LOTRIMIN 3 COMBINATION PACK","activeIngredients":"CLOTRIMAZOLE","strength":"1%,200MG","dosageForm":"CREAM, TABLET;TOPICAL, VAGINAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"GYNE-LOTRIMIN 3 COMBINATION PACK","submission":"CLOTRIMAZOLE","actionType":"1%,200MG","submissionClassification":"CREAM, TABLET;TOPICAL, VAGINAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.